A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment

Nerissa George, Ann Marie Liapakis, Kevin M. Korenblat, Tingting Li, David Roth, Jerry Yee, Kevin J. Fowler, Lehman Howard, Jingxia Liu, Mary C. Politi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rationale & Objective: Patient education and decision support tools could facilitate decisions around the timing of antiviral therapy in patients living with both hepatitis C virus (HCV) infection and chronic kidney disease (CKD). We previously developed a tool through the HELP (Helping Empower Liver and Kidney Patients) study. This article evaluates the preliminary efficacy and usability of the tool among participants with both HCV infection and CKD. Study Design: Pre-post study pilot evaluation. Setting & Participants: Participants were at least 18 years old, were English speaking, and had a diagnosis of chronic HCV infection and CKD; they were seen in CKD clinics, dialysis units, and/or hepatology and liver transplantation clinics. Intervention: Electronic patient decision support tool. Outcomes: Participants’ change in knowledge, certainty about choice, decision self-efficacy, patients’ treatment preferences, and tool usability. Results: 70 participants were recruited; 56 of 70 (80.0%) completed study procedures. Nearly all (51/56; 91.1%) requested paper-based study procedures despite the electronic design of the tool. Participants reported that they were most worried about the following treatment factors: (1) cost of drugs to treat HCV infection, (2) how their HCV infection affected their CKD, and (3) wait times for a kidney transplant. After using the decision tool, participants had significantly higher HCV infection and CKD knowledge (mean posttest percent of questions answered correctly = 65.74% vs pretest percent of questions answered correctly = 53.44%; P < 0.001) and more certainty about choice (mean posttest = 3.13 vs pretest = 2.65; P = 0.05). There were no significant changes in decision self-efficacy (mean posttest = 86.62 vs pretest = 84.68; P = 0.48). Limitations: Single-site pilot study to explore preliminary tool efficacy and usability. Conclusions: This study suggests that a decision tool may support informed patient-centered choices among patients with HCV infection and CKD. Future studies should evaluate ways to improve care decisions in a larger sample using both paper-based and electronic materials. Funding: Merck & Co, Inc, Kenilworth, NJ. Trial Registration: Registered at clinicaltrials.gov with study number NCT03426787.

Original languageEnglish (US)
Pages (from-to)200-206
Number of pages7
JournalKidney Medicine
Volume1
Issue number4
DOIs
StatePublished - Jul 1 2019

Fingerprint

Virus Diseases
Chronic Renal Insufficiency
Hepacivirus
Self Efficacy
Therapeutics
Kidney
Drug Costs
Patient Preference
Chronic Hepatitis C
Gastroenterology
Patient Education
Liver Transplantation
Antiviral Agents
Dialysis
Transplants
Liver

Keywords

  • chronic kidney disease
  • decision aid
  • decision support
  • hepatitis C virus
  • patient education

ASJC Scopus subject areas

  • Nephrology
  • Internal Medicine

Cite this

George, N., Liapakis, A. M., Korenblat, K. M., Li, T., Roth, D., Yee, J., ... Politi, M. C. (2019). A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment. Kidney Medicine, 1(4), 200-206. https://doi.org/10.1016/j.xkme.2019.06.003

A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment. / George, Nerissa; Liapakis, Ann Marie; Korenblat, Kevin M.; Li, Tingting; Roth, David; Yee, Jerry; Fowler, Kevin J.; Howard, Lehman; Liu, Jingxia; Politi, Mary C.

In: Kidney Medicine, Vol. 1, No. 4, 01.07.2019, p. 200-206.

Research output: Contribution to journalArticle

George, N, Liapakis, AM, Korenblat, KM, Li, T, Roth, D, Yee, J, Fowler, KJ, Howard, L, Liu, J & Politi, MC 2019, 'A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment', Kidney Medicine, vol. 1, no. 4, pp. 200-206. https://doi.org/10.1016/j.xkme.2019.06.003
George, Nerissa ; Liapakis, Ann Marie ; Korenblat, Kevin M. ; Li, Tingting ; Roth, David ; Yee, Jerry ; Fowler, Kevin J. ; Howard, Lehman ; Liu, Jingxia ; Politi, Mary C. / A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment. In: Kidney Medicine. 2019 ; Vol. 1, No. 4. pp. 200-206.
@article{983b2216242a4a1cb860ab946119f1e8,
title = "A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment",
abstract = "Rationale & Objective: Patient education and decision support tools could facilitate decisions around the timing of antiviral therapy in patients living with both hepatitis C virus (HCV) infection and chronic kidney disease (CKD). We previously developed a tool through the HELP (Helping Empower Liver and Kidney Patients) study. This article evaluates the preliminary efficacy and usability of the tool among participants with both HCV infection and CKD. Study Design: Pre-post study pilot evaluation. Setting & Participants: Participants were at least 18 years old, were English speaking, and had a diagnosis of chronic HCV infection and CKD; they were seen in CKD clinics, dialysis units, and/or hepatology and liver transplantation clinics. Intervention: Electronic patient decision support tool. Outcomes: Participants’ change in knowledge, certainty about choice, decision self-efficacy, patients’ treatment preferences, and tool usability. Results: 70 participants were recruited; 56 of 70 (80.0{\%}) completed study procedures. Nearly all (51/56; 91.1{\%}) requested paper-based study procedures despite the electronic design of the tool. Participants reported that they were most worried about the following treatment factors: (1) cost of drugs to treat HCV infection, (2) how their HCV infection affected their CKD, and (3) wait times for a kidney transplant. After using the decision tool, participants had significantly higher HCV infection and CKD knowledge (mean posttest percent of questions answered correctly = 65.74{\%} vs pretest percent of questions answered correctly = 53.44{\%}; P < 0.001) and more certainty about choice (mean posttest = 3.13 vs pretest = 2.65; P = 0.05). There were no significant changes in decision self-efficacy (mean posttest = 86.62 vs pretest = 84.68; P = 0.48). Limitations: Single-site pilot study to explore preliminary tool efficacy and usability. Conclusions: This study suggests that a decision tool may support informed patient-centered choices among patients with HCV infection and CKD. Future studies should evaluate ways to improve care decisions in a larger sample using both paper-based and electronic materials. Funding: Merck & Co, Inc, Kenilworth, NJ. Trial Registration: Registered at clinicaltrials.gov with study number NCT03426787.",
keywords = "chronic kidney disease, decision aid, decision support, hepatitis C virus, patient education",
author = "Nerissa George and Liapakis, {Ann Marie} and Korenblat, {Kevin M.} and Tingting Li and David Roth and Jerry Yee and Fowler, {Kevin J.} and Lehman Howard and Jingxia Liu and Politi, {Mary C.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.xkme.2019.06.003",
language = "English (US)",
volume = "1",
pages = "200--206",
journal = "Kidney Medicine",
issn = "2590-0595",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment

AU - George, Nerissa

AU - Liapakis, Ann Marie

AU - Korenblat, Kevin M.

AU - Li, Tingting

AU - Roth, David

AU - Yee, Jerry

AU - Fowler, Kevin J.

AU - Howard, Lehman

AU - Liu, Jingxia

AU - Politi, Mary C.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Rationale & Objective: Patient education and decision support tools could facilitate decisions around the timing of antiviral therapy in patients living with both hepatitis C virus (HCV) infection and chronic kidney disease (CKD). We previously developed a tool through the HELP (Helping Empower Liver and Kidney Patients) study. This article evaluates the preliminary efficacy and usability of the tool among participants with both HCV infection and CKD. Study Design: Pre-post study pilot evaluation. Setting & Participants: Participants were at least 18 years old, were English speaking, and had a diagnosis of chronic HCV infection and CKD; they were seen in CKD clinics, dialysis units, and/or hepatology and liver transplantation clinics. Intervention: Electronic patient decision support tool. Outcomes: Participants’ change in knowledge, certainty about choice, decision self-efficacy, patients’ treatment preferences, and tool usability. Results: 70 participants were recruited; 56 of 70 (80.0%) completed study procedures. Nearly all (51/56; 91.1%) requested paper-based study procedures despite the electronic design of the tool. Participants reported that they were most worried about the following treatment factors: (1) cost of drugs to treat HCV infection, (2) how their HCV infection affected their CKD, and (3) wait times for a kidney transplant. After using the decision tool, participants had significantly higher HCV infection and CKD knowledge (mean posttest percent of questions answered correctly = 65.74% vs pretest percent of questions answered correctly = 53.44%; P < 0.001) and more certainty about choice (mean posttest = 3.13 vs pretest = 2.65; P = 0.05). There were no significant changes in decision self-efficacy (mean posttest = 86.62 vs pretest = 84.68; P = 0.48). Limitations: Single-site pilot study to explore preliminary tool efficacy and usability. Conclusions: This study suggests that a decision tool may support informed patient-centered choices among patients with HCV infection and CKD. Future studies should evaluate ways to improve care decisions in a larger sample using both paper-based and electronic materials. Funding: Merck & Co, Inc, Kenilworth, NJ. Trial Registration: Registered at clinicaltrials.gov with study number NCT03426787.

AB - Rationale & Objective: Patient education and decision support tools could facilitate decisions around the timing of antiviral therapy in patients living with both hepatitis C virus (HCV) infection and chronic kidney disease (CKD). We previously developed a tool through the HELP (Helping Empower Liver and Kidney Patients) study. This article evaluates the preliminary efficacy and usability of the tool among participants with both HCV infection and CKD. Study Design: Pre-post study pilot evaluation. Setting & Participants: Participants were at least 18 years old, were English speaking, and had a diagnosis of chronic HCV infection and CKD; they were seen in CKD clinics, dialysis units, and/or hepatology and liver transplantation clinics. Intervention: Electronic patient decision support tool. Outcomes: Participants’ change in knowledge, certainty about choice, decision self-efficacy, patients’ treatment preferences, and tool usability. Results: 70 participants were recruited; 56 of 70 (80.0%) completed study procedures. Nearly all (51/56; 91.1%) requested paper-based study procedures despite the electronic design of the tool. Participants reported that they were most worried about the following treatment factors: (1) cost of drugs to treat HCV infection, (2) how their HCV infection affected their CKD, and (3) wait times for a kidney transplant. After using the decision tool, participants had significantly higher HCV infection and CKD knowledge (mean posttest percent of questions answered correctly = 65.74% vs pretest percent of questions answered correctly = 53.44%; P < 0.001) and more certainty about choice (mean posttest = 3.13 vs pretest = 2.65; P = 0.05). There were no significant changes in decision self-efficacy (mean posttest = 86.62 vs pretest = 84.68; P = 0.48). Limitations: Single-site pilot study to explore preliminary tool efficacy and usability. Conclusions: This study suggests that a decision tool may support informed patient-centered choices among patients with HCV infection and CKD. Future studies should evaluate ways to improve care decisions in a larger sample using both paper-based and electronic materials. Funding: Merck & Co, Inc, Kenilworth, NJ. Trial Registration: Registered at clinicaltrials.gov with study number NCT03426787.

KW - chronic kidney disease

KW - decision aid

KW - decision support

KW - hepatitis C virus

KW - patient education

UR - http://www.scopus.com/inward/record.url?scp=85069969070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069969070&partnerID=8YFLogxK

U2 - 10.1016/j.xkme.2019.06.003

DO - 10.1016/j.xkme.2019.06.003

M3 - Article

AN - SCOPUS:85069969070

VL - 1

SP - 200

EP - 206

JO - Kidney Medicine

JF - Kidney Medicine

SN - 2590-0595

IS - 4

ER -